文献速递生殖医学

女转男跨性别患者与顺性别患者的辅助生殖技术结局比较:生殖医学的新前沿

Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine.
PubMed 文献 · Fertil Steril · 2019-10-06

这项匹配回顾性队列研究比较了26例女转男跨性别患者与130例按年龄、体质指数和抗苗勒管激素匹配的顺性别患者的辅助生殖技术结局。跨性别组平均获卵数19.9±8.7个,顺性别组15.9±9.6个;两组峰值雌二醇水平相同;跨性别组促性腺激素总剂量更高(3,892 IU vs 2,599 IU)。26例中16例仅行卵母细胞冻存,7对夫妇行新鲜或冻融胚胎移植且均获活产。

要点

  • 跨性别组平均获卵数19.9±8.7个,顺性别组为15.9±9.6个。
  • 两组峰值雌二醇水平相同,跨性别组促性腺激素总剂量更高(3,892 IU vs 2,599 IU)。
  • 26例中16例仅冻存卵母细胞,7对夫妇行移植且均获活产。

核心结论

  • 这是首个该规模的女转男跨性别患者辅助生殖技术结局研究,结果可能让已启动睾酮治疗的患者及其照护者安心,结局可以很好。
  • 需进一步研究这些发现的普遍性,以及在不停止睾酮治疗的情况下能否获得类似结果。

研究设计与样本

  • 匹配回顾性队列研究,在体外受精门诊开展。
  • 女转男跨性别患者26例,2010年至2018年就诊;顺性别对照130例,同期按年龄、体质指数和抗苗勒管激素水平匹配。

主要发现

  • 跨性别组平均获卵数19.9±8.7个,顺性别组15.9±9.6个。
  • 两组峰值雌二醇水平相同。
  • 跨性别组促性腺激素总剂量高于顺性别组(3,892 IU vs 2,599 IU)。
  • 26例中16例仅行卵母细胞冻存;7对夫妇行新鲜或冻融胚胎移植,均获活产。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究这些发现的普遍性。
  • 需进一步研究在不停止睾酮治疗的情况下能否获得类似结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate assisted reproductive technology (ART) outcomes in a female-to-male transgender cohort and compare the results with those of a matched cisgender cohort. DESIGN: Matched retrospective cohort study. SETTING: In vitro fertilization clinic. PATIENT(S): Female-to-male transgender patients (n = 26) who sought care from 2010 to 2018. A cisgender cohort (n = 130) was matched during the same time period by age, body mass index, and antimüllerian hormone levels. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Cycle outcomes, including oocyte yield, number of mature oocytes, total gonadotropin dose, and peak E2 levels. RESULT(S): The mean number of oocytes retrieved in the transgender group was 19.9 ± 8.7 compared with 15.9 ± 9.6 in the cisgender group. Peak E2 levels were the same between the two groups. The total dose of gonadotropins used was higher in the transgender group compared with the cisgender group (3,892 IU vs. 2,599 IU). Of the 26 patients, 16 performed oocyte banking only. Seven couples had fresh or frozen transfers, with all achieving live births. CONCLUSION(S): This is the first study of this size investigating ART outcomes in female-to-male transgender patients. The findings may serve to reassure transgender patients and their care providers that outcomes can be excellent even if testosterone therapy has already been initiated. Further investigation needs to be performed on the generalizability of these findings, and whether similar results can be achieved without stopping testosterone therapy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Leung A, Sakkas D, Pang S, et al. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertil Steril. 2019. PMID: 31594633. doi:10.1016/j.fertnstert.2019.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。